The Indian Pharmaceutical Alliance Welcomes New Leadership to Drive the Next Phase of Growth

▴ The Indian Pharmaceutical Alliance
The Indian Pharmaceutical Alliance (IPA) today announced a leadership transition, with Dr. Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, assuming the role of President.

Mumbai, October 03, 2025: The Indian Pharmaceutical Alliance (IPA) today announced a leadership transition, with Dr. Sharvil Patel, Managing Director of Zydus Lifesciences and former Vice President of IPA, assuming the role of President. He succeeds Mr. Samir Mehta, Chairman, Torrent Group, who successfully guided the association in advancing its mission.

 

The IPA leadership team also includes Mr. Glenn Saldanha, Chairman and Managing Director, Glenmark, who has been appointed as Vice President.

 

The leadership transition comes at a pivotal moment for the Indian pharmaceutical industry. Recent GST reforms have set the stage for a more affordable and patient-centric healthcare ecosystem. At the same time, India continues to strengthen its position as a hub for specialty medicines, biosimilars, and cutting-edge therapies. The new IPA leadership will build on these strengths to further advance India’s contribution to global healthcare innovation.

 

Mr. Samir Mehta, Chairman, Torrent Group and Immediate Past President, IPA, said: “It has been a privilege to serve as President of IPA and work alongside an exceptional team of leaders committed to advancing India’s pharmaceutical sector. Together, we strengthened the industry’s voice and reinforced its role in delivering affordable and innovative healthcare solutions globally. I am confident that under the new leadership team, IPA will continue to shape the future of global healthcare.”

 

Dr. Sharvil Patel, Managing Director, Zydus Lifesciences and President, IPA, said: “I am honored to take on this role and thank Mr. Samir Mehta for his outstanding stewardship in strengthening IPA’s voice and impact. Building on this foundation, breakthroughs at Zydus, such as India’s first NCE, our foray into MedTech and the global CDMO business, and our advances in vaccines and biologics, inspire my vision to build a strong, self-reliant India.”

 

Mr. Glenn Saldanha, Chairman and Managing Director, Glenmark, and Vice President, IPA, added: “I am delighted to join the IPA leadership team and contribute to shaping the industry’s next chapter. Our recent global partnership with AbbVie is a strong example of how Indian pharma is moving up the innovation curve, and together we will strengthen India’s leadership in delivering high-quality, affordable, and future-ready healthcare solutions.”

 

Mr. Sudarshan Jain, Secretary General, IPA, said: “The Indian Pharmaceutical Industry has been playing a vital role in advancing the industry’s vision for patient care and access. With the new leadership team, we will continue to build on recent reforms and breakthroughs with a focus on innovation, patient access, and the highest standards of quality in healthcare.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026